Serge Atlaoui, 51, was arrested near Jakarta in 2005 in a secret laboratory producing ecstasy and was sentenced to death two years later.
Imprisoned in Indonesia for a decade, the father-of-four has always denied the charges, saying he was installing industrial machinery in what he thought was an acrylics factory.
He is one of several foreign drug convicts on death row in Indonesia who recently lost appeals for presidential clemency, typically a last chance to avoid the firing squad. They are expected to be executed once final legal appeals are resolved.
However Suhadi, one of the judges assessing his case, said the court rejected his application on Tuesday.
"A panel of three judges has rejected (the request) for a judicial review from Frenchman Serge Atlaoui," said Suhadi, who goes by one name and is also the Supreme Court spokesman.
He said there was no new evidence presented -- a requirement for a judicial review -- and the reasons put forward were not sufficient.
Several other death row convicts also have legal bids outstanding, including two high-profile Australian drug traffickers who have lost several appeals but are now taking their case to the Constitutional Court, although authorities insist they have no more options.
"Our family calls on President Francois Hollande and the European Union to do everything possible to save Serge Atlaoui from the firing squad," his brother Andre told AFP after the appeal was rejected, describing their "dismay", "suffering" and "lack of understanding" over the court's decision.
The French ambassador to Indonesia warned last week that executing Atlaoui would have "consequences" for relations between Paris and Jakarta.
Australia has issued a similar warning.
"Neither France nor Australia can tolerate the death penalty being imposed on our citizens at home or abroad," Australian Foreign Minister Julie Bishop said in Paris after meeting her counterpart Laurent Fabius.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
